Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108902206> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W3108902206 abstract "Aims. According to the need for the development of new anticancer agents, we have synthetized novel bioactive compounds and aimed to determine their antitumor action.Materials & Methods. We describe in vitro studies evaluating the effect of 35 novel chemical compounds on two triple negative murine mammary adenocarcinoma tumors.Results & Conclusions. Three compounds were selected because of their high antitumor activity and their low toxicity to normal cells. Their effect on tumor cells apoptosis, clonogenicity and migratory capacity, were determined. We found that the selected compounds showed inhibition of viability and clonogenic capacity, and promotion of apoptosis. They also decreased the migratory capacity of tumor cells. The results obtained suggest the likelihood of their future use as antitumor and/or antimetastatic agentsSM1: Methodology and characterization of the chemical compoundsSM2: Chemical structure of the compounds belonging to each familySM3: Effect of the compounds (100 µM) on 4T1 cells viability. Cells were incubated for 36 hs in complete medium with 100 µM of each compound. Viable cell number was evaluated with WST-1. Results are shown as percentage of cell viability relative to the non-treated control (100%) and expressed as mean ± SEM. Experiments were performed in triplicate.SM4: Effect of the compounds (75 µM) on 4T1 cells viability. Cells were incubated for 36 hs in complete medium with 75 µM of each compound. Viable cell number was evaluated with WST-1. Results are shown as percentage of cell viability relative to the non-treated control (100%) and expressed as mean ± SEM. Experiments were performed in triplicate.SM5: Effect of the compounds (50 and 25 µM) on 4T1 cells viability. A) Cells were incubated for 36 hs in complete medium with 50 µM of each compound; B) Cells were incubated for 36 hs in complete medium with 25 µM of each compound. Viable cell number was evaluated with WST-1. Results are shown as percentage of cell viability relative to the non-treated control (100%) and expressed as mean ± SEM. Experiments were performed in triplicate.SM6: The percent of viability of the selected compounds at 25 µM" @default.
- W3108902206 created "2020-12-07" @default.
- W3108902206 creator A5005300802 @default.
- W3108902206 creator A5006016730 @default.
- W3108902206 creator A5009304188 @default.
- W3108902206 creator A5013324734 @default.
- W3108902206 creator A5023069910 @default.
- W3108902206 creator A5023291545 @default.
- W3108902206 creator A5026376296 @default.
- W3108902206 creator A5056943347 @default.
- W3108902206 creator A5059410078 @default.
- W3108902206 creator A5064143352 @default.
- W3108902206 creator A5070248190 @default.
- W3108902206 creator A5075981294 @default.
- W3108902206 creator A5082008949 @default.
- W3108902206 creator A5088586444 @default.
- W3108902206 date "2020-11-12" @default.
- W3108902206 modified "2023-09-25" @default.
- W3108902206 title "Supplementary Materials - Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models" @default.
- W3108902206 hasPublicationYear "2020" @default.
- W3108902206 type Work @default.
- W3108902206 sameAs 3108902206 @default.
- W3108902206 citedByCount "0" @default.
- W3108902206 crossrefType "journal-article" @default.
- W3108902206 hasAuthorship W3108902206A5005300802 @default.
- W3108902206 hasAuthorship W3108902206A5006016730 @default.
- W3108902206 hasAuthorship W3108902206A5009304188 @default.
- W3108902206 hasAuthorship W3108902206A5013324734 @default.
- W3108902206 hasAuthorship W3108902206A5023069910 @default.
- W3108902206 hasAuthorship W3108902206A5023291545 @default.
- W3108902206 hasAuthorship W3108902206A5026376296 @default.
- W3108902206 hasAuthorship W3108902206A5056943347 @default.
- W3108902206 hasAuthorship W3108902206A5059410078 @default.
- W3108902206 hasAuthorship W3108902206A5064143352 @default.
- W3108902206 hasAuthorship W3108902206A5070248190 @default.
- W3108902206 hasAuthorship W3108902206A5075981294 @default.
- W3108902206 hasAuthorship W3108902206A5082008949 @default.
- W3108902206 hasAuthorship W3108902206A5088586444 @default.
- W3108902206 hasConcept C117262875 @default.
- W3108902206 hasConcept C121608353 @default.
- W3108902206 hasConcept C1491633281 @default.
- W3108902206 hasConcept C178790620 @default.
- W3108902206 hasConcept C185592680 @default.
- W3108902206 hasConcept C190283241 @default.
- W3108902206 hasConcept C202751555 @default.
- W3108902206 hasConcept C2781182431 @default.
- W3108902206 hasConcept C29730261 @default.
- W3108902206 hasConcept C502942594 @default.
- W3108902206 hasConcept C53227056 @default.
- W3108902206 hasConcept C54355233 @default.
- W3108902206 hasConcept C55493867 @default.
- W3108902206 hasConcept C71240020 @default.
- W3108902206 hasConcept C86803240 @default.
- W3108902206 hasConceptScore W3108902206C117262875 @default.
- W3108902206 hasConceptScore W3108902206C121608353 @default.
- W3108902206 hasConceptScore W3108902206C1491633281 @default.
- W3108902206 hasConceptScore W3108902206C178790620 @default.
- W3108902206 hasConceptScore W3108902206C185592680 @default.
- W3108902206 hasConceptScore W3108902206C190283241 @default.
- W3108902206 hasConceptScore W3108902206C202751555 @default.
- W3108902206 hasConceptScore W3108902206C2781182431 @default.
- W3108902206 hasConceptScore W3108902206C29730261 @default.
- W3108902206 hasConceptScore W3108902206C502942594 @default.
- W3108902206 hasConceptScore W3108902206C53227056 @default.
- W3108902206 hasConceptScore W3108902206C54355233 @default.
- W3108902206 hasConceptScore W3108902206C55493867 @default.
- W3108902206 hasConceptScore W3108902206C71240020 @default.
- W3108902206 hasConceptScore W3108902206C86803240 @default.
- W3108902206 hasLocation W31089022061 @default.
- W3108902206 hasOpenAccess W3108902206 @default.
- W3108902206 hasPrimaryLocation W31089022061 @default.
- W3108902206 hasRelatedWork W1492504880 @default.
- W3108902206 hasRelatedWork W1517309759 @default.
- W3108902206 hasRelatedWork W1973882202 @default.
- W3108902206 hasRelatedWork W1980909597 @default.
- W3108902206 hasRelatedWork W2066300890 @default.
- W3108902206 hasRelatedWork W2112187852 @default.
- W3108902206 hasRelatedWork W2125194411 @default.
- W3108902206 hasRelatedWork W2180193251 @default.
- W3108902206 hasRelatedWork W2254612149 @default.
- W3108902206 hasRelatedWork W2367956824 @default.
- W3108902206 hasRelatedWork W2392553940 @default.
- W3108902206 hasRelatedWork W2427319065 @default.
- W3108902206 hasRelatedWork W2563331941 @default.
- W3108902206 hasRelatedWork W2603159715 @default.
- W3108902206 hasRelatedWork W2761156473 @default.
- W3108902206 hasRelatedWork W2965937593 @default.
- W3108902206 hasRelatedWork W3102337599 @default.
- W3108902206 hasRelatedWork W3121223100 @default.
- W3108902206 hasRelatedWork W569523159 @default.
- W3108902206 hasRelatedWork W2185187775 @default.
- W3108902206 isParatext "false" @default.
- W3108902206 isRetracted "false" @default.
- W3108902206 magId "3108902206" @default.
- W3108902206 workType "article" @default.